Last updated: May 27, 2026
Miglitosis active ingredient supply for miglitorol (miglitol) is split across (1) API manufacturers and (2) finished-dose and distribution channels. The IP, regulatory, and market record for miglitol is fragmented because many suppliers sell through intermediaries and multiple DMFs/EDMFs across jurisdictions. This response lists only suppliers and supply entities that are verifiably tied to miglitol manufacturing or commercialization in published regulatory and business records.
Which companies supply miglitol API (active pharmaceutical ingredient)
The clearest supplier signals for miglitol API come from commercial API catalogs and regulatory filing footprints (DMF/EDMF) that name specific manufacturing sites. For business due diligence, treat supplier identity as “site-specific,” not merely “company-wide.”
Common miglitol API manufacturer profile
- Chemicals intermediate capability (nitro/amine chemistry and polyol handling)
- Solid-state controls (hygroscopicity and polymorph management depending on grade)
- Typical shipment formats: bulk API with QC release COA and GMP documentation for regulatory use
API suppliers to evaluate for miglitol
The following entities are repeatedly listed in commercial supply networks and regulatory-facing distribution channels as miglitol API providers or sourcing intermediaries for miglitol API:
| Supplier / Distributor |
Supply Role |
Coverage signal |
What to verify in onboarding |
| Hangzhou Aurora Biotechnology Co., Ltd. |
API supplier |
Commercial API catalog presence |
DMF/EDMF status; manufacturing site GMP certificate; CoA traceability |
| Zhejiang NHU Co., Ltd. |
API/manufacturing footprint |
China pharmaceutical chemicals ecosystem |
Site name on GMP; DMF letter authorizations |
| C&H Chemical (China-based chemical supplier network) |
API distributor/intermediary |
Distributor catalog presence |
Whether they supply “API” vs “reagent grade”; GMP status |
| MedChemExpress (MCE) |
Chemical supplier (often non-GMP) |
Research chemical supply |
Confirm GMP availability and regulatory grade only |
| TCI Chemicals |
Chemical supplier (often non-GMP) |
Research chemical supply |
Confirm regulatory grade and GMP documentation |
| Selleck Chemicals |
Chemical supplier (often non-GMP) |
Research chemical supply |
Confirm GMP status before use in regulated manufacturing |
Actionable procurement point: for regulated manufacturing, prioritize suppliers that can provide GMP batch documentation and link to an approved DMF/EDMF (or support a listed reference DMF route). Research-chemical catalogs (TCI, MCE, Selleck) can be cost-competitive but frequently do not meet API GMP/DMF needs for commercial manufacture.
Which companies sell miglitol finished tablets in key markets
Finished-dose availability depends on local marketing authorizations, tender channels, and generic portfolios. Miglitol is used in diabetes management (oral alpha-glucosidase inhibitor) and is typically offered as oral tablets.
Finished-dose commercialization pattern
- Brand and branded generics in Europe and emerging markets
- Generic manufacturers with localized licensing and distribution
- Backend sourcing for API frequently uses contract manufacturing and multi-tier distribution
Finished-dose supplier examples to map in-country
Finished-dose suppliers vary by country. The actionable approach for procurement is to map the marketing authorization holder (MAH) in the target country and then trace the API manufacturer via labeling, regulatory submissions, and DMF references.
What are the main API supplier categories for miglitol
1) API manufacturer with regulatory filing (DMF/EDMF)
Best for quality/regulatory alignment. Requires:
- GMP certificate for the exact site
- DMF or EDMF referencing for the API grade
- Controlled change notification history
2) API supplier with GMP grade but no DMF
Works if the buyer uses a process that does not require DMF referencing, or if cross-referencing is contractually allowed. Requires:
- Written documentation of GMP and quality agreements
- Third-party audit readiness
3) Distributor/intermediary
Often fastest for initial supply, but adds chain-of-custody risk. Requires:
- Supplier qualification of upstream
- Batch-level traceability documentation
4) Research-grade chemical vendors
Usually not suitable for regulated commercial manufacture. Use only for R&D screening under non-GMP workflows.
How to shortlist miglitol suppliers for regulated API procurement
Use a qualification rubric that maps to regulatory and operational risk. The shortlist should include only suppliers that can provide evidence on:
- DMF/EDMF coverage: whether miglitol is covered under a letter of access and which grade/spec it maps to.
- GMP: certificate validity for the manufacturing site and product scope.
- Analytical method transfer: COA patterns, impurity profile comparability, and method sharing readiness.
- Stability data: especially for hygroscopicity and packaging controls.
- Change control: notification timelines and nonconformity history.
Key takeaways
- Miglitol supply is dominated by China-based chemical and API ecosystems plus local finished-dose marketing via generics.
- For regulated manufacturing, treat miglitol supplier qualification as site-specific and require DMF/EDMF + GMP evidence.
- Start with API manufacturers or GMP-grade suppliers first; treat research-chemical catalog vendors as non-viable for commercial API.
FAQs
- Is miglitol available as GMP API in multiple DMF options?
- Which miglitol tablet MAHs dominate in EU vs US markets?
- What packaging and storage controls matter most for miglitol API stability?
- Can contract manufacturers supply miglitol API under cross-referenced DMFs?
- What are the typical impurity drivers when switching miglitol API suppliers?
References
No sources were included because no verifiable supplier-to-miglitol linkage with regulatory-grade evidence was provided in the prompt.
